MYTIGATE is the IT platform for digitalizing risk management for the pharmaceutical supply chain: Since the introduction of the EU GDP Guidelines in 2013, pharma companies are required to conduct a risk-based selection process for their transport partners. Until now, however, they have not been able to meet these requirements. MYTIGATE offers a new solution that will help pharma companies to be compliant and select lanes using those supply chain partners that offer the lowest risk.
Risks are continuously calculated, starting from the design phase of the lane through to the operating phase. The calculation of these risks is based on a scientific model and uses information from both supply chain partners (certificates, self-assessment of capabilities, validation information) and pharma companies (operational deviations, root cause data, temperature logger data).
Our pharma industry partners expect annual cost savings >200,000 €/year due to fewer scrapping cases, reduced insurance premiums, lower packaging costs and better root cause analyses. MYTIGATE is a must for state-of-the-art risk management within the pharma supply chain.
MYTIGATE’s vision is to become the standard for the pharma industry and possibly for the forwarder industry as well.